Telmisartan and Amlodipine Besylate Tablets 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
JW Pharmaceutical Corp.
MFDS item code 201906172 · Approved 2019.08.29
This product's status changed to Expired on 2024.08.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with chronic hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan. It effectively lowers blood pressure in these patients, helping to reduce the risk of cardiovascular complications.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended to initiate treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Cautious Administration’). In older adults aged 75 years or over, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to individuals who are allergic to the active ingredients or components, patients with severe liver impairment or hypotension, patients with serious heart problems, and those with specific kidney diseases. Patients with impaired liver function or biliary obstruction should use this medication with caution, and dose adjustments may be necessary. Patients with ulcers or inflammation in the stomach are advised to be cautious when taking this medication, as there is a risk of gastrointestinal bleeding and other side effects. Patients with reduced kidney function or issues with kidney blood vessels may experience worsening kidney function while taking this medication, so regular check-ups are necessary. Elderly patients may be more sensitive to this medication, so it is advisable to start with a lower initial dose and gradually increase it. As this medication lowers blood pressure, dizziness or hypotensive symptoms may occur after administration, so caution is advised when driving or operating machinery. There may be interactions with other medications, so it is essential to consult a doctor or pharmacist if the patient is taking diuretics, potassium supplements, heart medications, anticoagulants, or analgesics. In cases of overdose, severe hypotension, dizziness, and abnormal heart rhythms may occur, so it is essential to adhere strictly to the prescribed dosage and seek medical attention immediately if unusual symptoms arise. This medication is not recommended for children as safety and efficacy have not been sufficiently established, nor is it advisable for breastfeeding women.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a special container that prevents light from entering, as it is sensitive to light. Additionally, it should be kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.
The tablet is a white and light gray, biconvex, oval-shaped double tablet.
30 tablets/PTP [30 tablets (10 tablets/Alu-Alu × 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.